Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development (Q35789894)
Jump to navigation
Jump to search
scientific article published on June 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development |
scientific article published on June 2004 |
Statements
1 reference
Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development (English)
1 reference
John W Park
1 reference
Robert S Kerbel
1 reference
Gary J Kelloff
1 reference
J Carl Barrett
1 reference
Bruce A Chabner
1 reference
David R Parkinson
1 reference
Jonathan Peck
1 reference
Raymond W Ruddon
1 reference
Caroline C Sigman
1 reference
Dennis J Slamon
1 reference
1 reference
Identifiers
1 reference